Zyversa Therapeutics Inc (ZVSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZVSA | AMGN | BMY | VRTX | GILD |
| Company | Zyversa Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 1.1300 | 293.55 | 59.98 | 456.58 | 90.75 |
| High | 1.1400 | 297.32 | 60.68 | 461.88 | 91.37 |
| Low | 1.1000 | 293.50 | 58.86 | 455.83 | 89.50 |
| Last | 1.1150 | 295.16 | 58.89 | 459.22 | 89.74 |
| Change | -0.0150 | +0.63 | +0.02 | +8.25 | -0.45 |
| % Change | -1.33% | +0.21% | +0.03% | +1.83% | -0.50% |
| Volume | 44,282 | 757,962 | 4,576,656 | 449,351 | 2,575,788 |
| 20-Day Average Volume | 3,578,986 | 2,940,404 | 12,207,496 | 1,354,609 | 7,286,441 |
| Previous Close | 1.1300 | 294.53 | 58.87 | 450.97 | 90.19 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.4908 | 305.20 | 56.58 | 477.03 | 91.00 |
| 20-Day Raw Stochastic | 3.21% | 37.26% | 75.95% | 18.76% | 28.16% |
| 20-Day Relative Strength | 33.09% | 40.64% | 62.28% | 44.46% | 53.20% |
| Weighted Alpha | -91.50 | +2.64 | +27.19 | +21.45 | +23.05 |
| Today's Opinion | 100% Sell | 72% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Buy | 24% Sell | 80% Buy |
| Last Month's Opinion | 100% Sell | 8% Buy | 72% Buy | 40% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.08% since 11/18/24 | +5.89% since 11/18/24 | +3.75% since 11/18/24 | -1.70% since 11/18/24 | +1.39% since 11/18/24 |
| Low | 1.0600 on 11/22/24 | 275.56 on 11/19/24 | 56.10 on 11/19/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 1.2899 on 11/19/24 | 297.32 on 11/25/24 | 60.59 on 11/25/24 | 463.90 on 11/19/24 | 91.36 on 11/25/24 |
| 1-Month | |||||
| %Chg | -46.90% since 10/25/24 | -6.87% since 10/25/24 | +13.50% since 10/25/24 | -3.90% since 10/25/24 | +0.78% since 10/25/24 |
| Low | 1.0401 on 11/15/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 3.3700 on 11/05/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -62.33% since 08/23/24 | -10.22% since 08/23/24 | +22.49% since 08/23/24 | -4.61% since 08/23/24 | +16.91% since 08/23/24 |
| Low | 1.0401 on 11/15/24 | 275.56 on 11/19/24 | 47.55 on 09/09/24 | 445.00 on 11/21/24 | 76.42 on 08/26/24 |
| High | 3.3700 on 11/05/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -74.13% since 05/24/24 | -3.48% since 05/24/24 | +42.90% since 05/24/24 | +0.46% since 05/24/24 | +36.56% since 05/24/24 |
| Low | 1.0401 on 11/15/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 6.3000 on 07/10/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,649 | 158,319,600 | 119,398,784 | 116,137,848 | 112,400,728 |
| Shares Outstanding, K | 2,344 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -98,300,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -2,400,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.65 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.43 on 11/14/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/12/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.08 | 49.77 | 0.00 | 20.26 |